Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

MD Anderson Launches Cell Therapy Institute

By Susan Haigney

November 11th 2024

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.

Aseptic Micro-Connector

By Pharmaceutical Technology Editors

November 1st 2024

CPC’s MicroCNX ULT Series represents the first aseptic microconnector that can be fitted directly into freeze cassettes for GCT production.

Cryoport and SK pharmteco Partner on Cell and Gene Therapies

By Susan Haigney

September 27th 2024

The two companies are partnering to provide logistics and manufacturing services to biotechnology and pharma companies.

...

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777